PMID: 8966223Feb 1, 1996Paper

Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192)

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
M PernotE Luporsi

Abstract

Eighty-five bladder cancers were treated at the Urology Clinic of Nancy and the Centre Alexis Vautrin from 1975 to 1992 with short course preoperative radiation therapy (3 x 3.5 Gy), conservative surgery and brachytherapy by iridium-192. The tumours were classified according to the 1979 UICC pTNM classification. There were 27 pT1, 31 pT2 and 22 pT3, two pT4 and three pTx. The pT1-pT2 cases received only one brachytherapy (50 Gy at least) after the short course preoperative irradiation. The pT3 cases received only 30 Gy of brachytherapy and an external irradiation boost (generally 40 Gy to the node areas and 30 Gy to the tumour, but the dose varied during the time course). Surgery was often preceded by an endoscopic resection consisting of a tumoral resection or a partial cystectomy according to the localisation. The plastic vector tubes were put into place at the time of partial cystectomy. Until 1983 the radioactive wires were loaded into the vector tubes on the day following surgery, thereafter it was done one week later. The 85 patients were classified into two groups: 63 patients who were untreated previously and 22 patients who had received one or more endoscopic resections for recurrences. The median follow-up was 84 mont...Continue Reading

References

Jan 1, 1978·The Journal of Urology·K B CummingsR P Gibbons
Jul 1, 1977·The Journal of Urology·R BarnesJ Dexter
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·S A ReisingerS G Mulholland
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·R RozanJ Douchez
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·W De NeveJ G Ribot
Feb 1, 1992·The Journal of Urology·G R EureP F Schellhammer
Mar 1, 1990·The Journal of Urology·U K WenderothR E Hautmann
Feb 1, 1989·International Journal of Radiation Oncology, Biology, Physics·B H van der Werf-Messing, W L van Putten
Feb 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J J Battermann, A H Tierie
Dec 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J J MazeronB Pierquin
Apr 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J T Parsons, R R Million
Dec 1, 1987·The Journal of Urology·H W HerrW F Whitmore
Feb 1, 1988·International Journal of Radiation Oncology, Biology, Physics·K L StrausJ E Tomaszewski
Apr 1, 1986·International Journal of Radiation Oncology, Biology, Physics·A Wijnmaalen, B H van der Werf-Messing
Jan 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J J MazeronB Pierquin
Nov 1, 1984·The Journal of Urology·O M Lilien, M Camey
Apr 1, 1983·International Journal of Radiation Oncology, Biology, Physics·B van der Werf-MessingW C Hop
Mar 1, 1981·International Journal of Radiation Oncology, Biology, Physics·B van der Werf-Messing, W C Hop

❮ Previous
Next ❯

Citations

Feb 15, 2005·International Journal of Radiation Oncology, Biology, Physics·Floris PosHarry Bartelink
Jun 14, 2002·International Journal of Radiation Oncology, Biology, Physics·Elzbieta M Van der Steen-BanasikJan Willem Leer
Dec 10, 1997·International Journal of Radiation Oncology, Biology, Physics·A WijnmaalenW L van Putten
Jun 22, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C C E KoningB R Pieters
Mar 10, 2001·American Journal of Clinical Oncology·Z PetrovichL W Brady
May 22, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Elzbieta van der Steen-BanasikAndries G Visser
Sep 21, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Renaud de CrevoisierChristine Haie-Meder
Dec 27, 2005·International Journal of Radiation Oncology, Biology, Physics·Floris J PosPeter Sminia
Apr 28, 2016·Der Urologe. Ausg. A·C NiedworokA Stenzl
Jun 15, 2016·International Journal of Radiation Oncology, Biology, Physics·Elzbieta M van der Steen-BanasikAndries G Visser
Jan 5, 2017·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Bradley R PietersErik Van Limbergen
Mar 27, 2021·Clinical Oncology : a Journal of the Royal College of Radiologists·S HafeezUNKNOWN RAIDER Trial Management Group
Nov 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C C E KoningB R Pieters

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved